Form 4 for ALKS Alkermes plc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001520262-26-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-03-02 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $29.72 | -9,000 | 89.4K | -9% | -$267.5K |
| D | 2026-03-04 | 2026-03-02 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $19.34 | +5,000 | 98.4K | +5% | +$96.7K |
| D | 2026-03-04 | 2026-03-02 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -5,000 | 21.4K | -19% | $0 |
| DM | 2026-03-04 | 2026-03-02 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | A - Grant | $0.00 | +121.6K | 83.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-02 | S | D | 9,000 | $29.72 | 89,389 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.29 to $30.13. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 2 | Common | Ordinary Shares | 2026-03-02 | M | A | 5,000 | $19.34 | 98,389 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | M | D | 5,000 | $0.00 | 21,356 | D | $19.34 · — to 2031-02-22 | 5,000 Ordinary Shares | (F4) These options are fully vested in accordance with their terms. |
| 4 | Derivative | Restricted Stock Unit Award | 2026-03-02 | A | A | 38,568 | $0.00 | 38,568 | D | — · — to — | 38,568 Ordinary Shares | (F6) Each restricted stock unit represents a contingent right to receive one ordinary share. (F7) Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-02 | A | A | 83,037 | $0.00 | 83,037 | D | $30.25 · — to 2036-03-02 | 83,037 Ordinary Shares | (F5) Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. |